Company profile for EsoCap

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

EsoCap’s vision is to improve the lives of patients affected by esophageal diseases. The esophagus is a particularly challenging environment, as swallowed drugs only remain in the area between the mouth and the stomach for a few seconds. EsoCap, a privately funded company based in Basel, Switzerland, has developed a novel solution designed to provide targeted and long-lasting local therapy in the upper gastrointestinal trac...
EsoCap’s vision is to improve the lives of patients affected by esophageal diseases. The esophagus is a particularly challenging environment, as swallowed drugs only remain in the area between the mouth and the stomach for a few seconds. EsoCap, a privately funded company based in Basel, Switzerland, has developed a novel solution designed to provide targeted and long-lasting local therapy in the upper gastrointestinal tract.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Malzgasse 9, CH-4052 Basel
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/12/17/2998035/0/en/EsoCap-announces-publication-of-comprehensive-Phase-II-results-demonstrating-ESO-101-s-effectiveness-in-eosinophilic-esophagitis.html

GLOBENEWSWIRE
17 Dec 2024

https://www.globenewswire.com/news-release/2023/12/05/2790628/0/en/EsoCap-reports-positive-topline-results-from-ACESO-Phase-II-trial-investigating-ESO-101-in-eosinophilic-esophagitis.html

GLOBENEWSWIRE
05 Dec 2023

https://www.globenewswire.com//news-release/2023/09/05/2736974/0/en/EsoCap-completes-patient-recruitment-in-ACESO-Phase-II-trial-in-eosinophilic-esophagitis.html

GLOBENEWSWIRE
05 Sep 2023

https://www.globenewswire.com/news-release/2022/06/14/2461781/0/en/EsoCap-holds-a-multidisciplinary-advisory-board-meeting-on-Barrett-s-esophagus.html

GLOBENEWSWIRE
14 Jun 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty